Atherectomy is defined as minimally invasive surgery for removal of plaque blockages from coronary and peripheral vessels. Perpetual rise in incidence of arterial blockages, particularly facilitated by the growth in geriatric population and cardiovascular diseases majorly contribute to the rise in the number of atherectomy procedures. Due to technological advancements, surgeons are replacing their existing atherectomy devices with novel solutions, as these replacements are found to be more efficient, safe and come with lesser complications.

The purpose of this research study titled ‘Atherectomy Devices Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global atherectomy devices market. This report presents and analyzes the major trends prevalent in the global Atherectomy Devices Market and the market size and forecast.

This report categorizes the global atherectomy devices market in terms of device type, disease site, and geographical distribution. Based on device type, the global atherectomy devices market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and laser atherectomy devices. Coronary artery disease and peripheral artery disease are the disease sites considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of device type, disease site, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global atherectomy devices market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the atherectomy devices market. The key players profiled in this report are Avinger, Inc., Boston Scientific Corporation, Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA Inc. (Volcano Corporation), Straub Medical AG, St. Jude Medical, LLC., and Terumo Interventional Systems.

High prevalence of peripheral artery diseases worldwide is opening up the demand for atherectomy devices. The market for atherectomy devices is also driven by growing preference for minimally invasive surgeries due to offered advantages such as lesser blood loss and risk of infection, quick procedural and recovery period. Among the considered device types, directional atherectomy devices segment currently dominates the market, followed by rotational devices. Orbital atherectomy systems is a relatively newer concept and helps in treating patients in a higher complex stage of disease. High revolving speed of these devices assist quicker procedure and retain the shape of small tissues while ensuring harmless excretion blockage of blockage. Orbital atherectomy devices are used treatment of both coronary and peripheral artery diseases.

Between the considered disease sites, peripheral artery diseases capture the largest revenue share in the global atherectomy devices market. The clinical term peripheral artery disease is used for classifying occlusive or stenotic lesions due to thromboembolic or atherosclerotic disease. Patients with peripheral arterial disease often require invasive procedures to alleviate blockage and disease progression. Percutaneous transluminal angioplasty and balloon angioplasty are conventionally used for treating focal lesions. However, risk of recoil, and lack of sufficient patency rates for long lesions limit the demand for these procedures. In addition, presence of rigid calcifications may also lead to incomplete or partial stent expansion and residual stenosis. Therefore, lack of therapies for restenosis has led to seeking out for alternative treatments such as modification of plaque with atherectomy. Directional atherectomy is most commonly used for treating peripheral artery disease. These devices use carbide rotating cutters that resect and remove plaque. These devices have a proven advantage in reducing the risk of barotrauma and thus reduce the risk of dissection and neointinal hyperplasia. However, distal embolization is a major concern with directional devices and the need for use of distal protection devices is also felt in cases of heavily calcified lesions.

Geographically, the global atherectomy devices market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global atherectomy devices market. In North America and globally, the United States captures the largest revenue share. Higher prevalence of coronary and peripheral artery diseases, better awareness in patient population and physicians and evolved reimbursement scenario are the key factors driving the North America and Europe markets. Additionally, domicile of major market players thus ensuring early bird advantage also facilitate the market growth of these regions. Furthermore, Asia Pacific is anticipated to be the fastest progressing regional market for atherectomy devices. Growing awareness, rapid development of healthcare infrastructure and perpetual growth in the prevalence of lifestyle-related diseases and obesity are the main driving factors for Asia Pacific atherectomy devices market.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Atherectomy Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Atherectomy Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Atherectomy Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Atherectomy Devices market?
• Which is the largest regional market for Atherectomy Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Atherectomy Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Atherectomy Devices market worldwide?